New Payment Policy Effective May 1, 2022

 Effective May 1, 2022: New Payment Policy - Genetic and Molecular Testing Services 

Superior HealthPlan presents a new payment policy to communicate the expanded requirements for billing of molecular and genetic testing to advance the reliability of laboratory quality information and reduce variability in billing. As a result, the following policy has been added, and is posted on Superior’s Clinical, Payment and Pharmacy Policies website for review, prior to its implementation. 


  • Genetic and Molecular Testing Services TX.PP.551

Effective Date 

  • 05/01/2022

Applicable Products 

  • Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, Health Insurance Marketplace (Ambetter from Superior HealthPlan, Medicare (Wellcare By Allwell) 

New Policy Overview Or Updated Policy Revisions 

  • To verify the accuracy of a test catalog and review coding engine standards for each molecular and genetic test, laboratories billing for genetic and molecular testing services should register using the Concert Genetics portal 

  • The portal offers a quality metrics questionnaire for completion by laboratories that leverages industry-standard quality programs with customization to reflect the unique characteristics of genetic testing while being minimally burdensome on some providers. 

  • Laboratories can also utilize the Concert Portal to obtain access to the Genetic Testing Unit, a unique identifier for every genetic test for billing and payment. 

Get contracted with Ambetter through Agility Insurance Services Now! 

Popular posts from this blog

Oscar Health 2022 Bonus Program

Bright HealthCare 2022 Early Bonus Blitz Program

HealthSherpa: Multiple Enrollment Groups (Split Policies)